Adams Diversified Equity Fund’s Halozyme HALO Stock Holding History

Adams Diversified Equity Fund’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-26,700	Closed	-$391K	–	231
2018 Q4	$391K	Sell	26,700 -1,200	-4%	-$19.1K	0.02%	193
2018 Q3	$507K	Sell	27,900 -2,000	-7%	-$35K	0.03%	196
2018 Q2	$504K	Sell	29,900 -2,500	-8%	-$47.3K	0.03%	205
2018 Q1	$635K	Buy	+32,400	New	+$627K	0.03%	170

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Adams Diversified Equity Fund's HALO Position: Q1 2019 in Review

Adams Diversified Equity Fund sold out of Halozyme (HALO) in Q1 2019, closing a stake of 26,700 shares — an estimated $391K sold.

Adams Diversified Equity Fund first reported a position in HALO in Q1 2018 and held it in 4 quarters. The position peaked at $635K in Q1 2018. 201 funds tracked by Wall St. Rank hold HALO as of Q1 2019.

Adams Diversified Equity Fund reported no remaining Halozyme position as of Q1 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 26,700 Halozyme shares in Q1 2019, an estimated $391K.
Adams Diversified Equity Fund first reported a position in Halozyme in Q1 2018 and held it in 4 quarters.
Adams Diversified Equity Fund's Halozyme position peaked at $635K in Q1 2018.
201 funds tracked by Wall St. Rank held Halozyme as of Q1 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2019, filed 26 Apr 2019.